ECU
INSM icon

Eisler Capital (US)’s Insmed INSM Stock Holding History

Eisler Capital (US)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,739
Closed -$2.13M – 554
2024
Q2 		$2.13M Buy
31,739
+5,526
+21% +$214K 0.04% 347
2024
Q1 		$711K Buy
+26,213
New +$734K 0.02% 444

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eisler Capital (US)'s INSM Position: Q3 2024 in Review

Eisler Capital (US) sold out of Insmed (INSM) in Q3 2024, closing a stake of 31,739 shares — an estimated $2.13M sold.

Eisler Capital (US) first reported a position in INSM in Q1 2024 and held it in 2 quarters. The position peaked at $2.13M in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Eisler Capital (US) reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 31,739 Insmed shares in Q3 2024, an estimated $2.13M.
  • Eisler Capital (US) first reported a position in Insmed in Q1 2024 and held it in 2 quarters.
  • Eisler Capital (US)'s Insmed position peaked at $2.13M in Q2 2024.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.